137 results on '"Guglielmi, Cesare"'
Search Results
2. Outcome of patients developing GVHD after DLI for CML relapse post HSCT: a retrospective study from the CLWP of the EBMT
3. Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: evidence for concomitant TCRγ/IGH rearrangements in the Hodgkin-like neoplastic cells
4. Follicular Lymphoma International Prognostic Index
5. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
6. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linfomi
7. CD56 Expression Is an Indicator of Poor Clinical Outcome in Patients With Acute Promyelocytic Leukemia Treated With Simultaneous All-Trans-Retinoic Acid and Chemotherapy
8. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA Archive of Adult Acute Leukaemia
9. Flt3L induces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures
10. A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients
11. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
12. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases sup *
13. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
14. S-100 + lymph node neoplasm: Report of a case with histological AL and immunological features intermediate between T cell lymphoma and malignant histiocytosis
15. Acute lymphocytic leukemia and complement receptors: A study of 45 cases
16. Three Cases of Therapy-related Acute Myeloid Leukaemia In Patients With Multiple Sclerosis: the Role of Arsenic Trioxide In the Treatment of Secondary Apl
17. Decreasing impact of relapse on death rate after allogeneic haematopoietic stem cell transplant in patients with chronic myeloid leukaemia: a multi-state modelling study
18. May we predict a 'pure' Graft versus Leukemia Effect after Donor Lymphocyte Infusions for chronic myeloid Leukemia relapsing after allogeneic Stem Cell Transplant ?
19. Transplant Centre Experience and Patient Selection Are the Key Elements Associated with Outcome of RIC and MAC HSCT for CML
20. Decreasing Impact of Relapse on Death Rate after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Chronic Myeloid Leukemia: a multi-state modelling study
21. Unrelated cord blood transplant (CBT) in patients with high risk leukaemia: a long-term follow-up
22. Search for unrelated cord blood (CB) unit for transplantation of high risk leukemic patients
23. Cord blood transplant (CBT) from unrelated mismatched donor in high risk (HR) leukemia
24. Immunophenotype of adult and childhood acute lymphoblastic leukemia: Changes at 1st relapse and clinico-prognostic implications
25. Il trapianto di cellule staminali da sangue di cordone ombellicale
26. Ricerca di unità di sangue di cordone ombellicale (SCO) da donatore non correlato per trapianto allogenico in pazienti affetti da leucemia ad alto rischio
27. Trapianto di sangue da cordone ombelicale (SCO) da donatore non familiare in pazienti con leucemia acuta ad alto rischio
28. Donor Lymphocyte Infusions (DLI) After Peripheral Blood Stem Cell Transplantation. A Retrospective Analysis of 357 Patients by the Chronic Leukemias Working Party EBMT.
29. Transplant Centre Experience and Patient Selection Are the Key Elements Associated with Outcome of RIC and MAC HSCT for CML.
30. THE F-MACHOP REGIMEN IN ADVANCED DIFFUSE AGGRESSIVE LYMPHOMAS - SUMMARY OF 10 YEARS EXPERIENCE AT A SINGLE INSTITUTION
31. Immunophenotype and clinical presentation in T-cell acute lymphoblastic leukemia
32. Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period
33. Donor Lymphocyte Transfusion (DLT) in the Treatment of Relapsed CML after Allogeneic PBSCT - A Retrospective Analysis of 346 Patients by the EBMT Chronic Leukemia Working Party.
34. Outcome of Patients Developing GVHD after DLI for CML Relapse from HLA-Identical Sibling or VUD HSCT.
35. Donor Lymphocyte Infusions from Unrelated Donors for Treatment of Relapsed Chronic Myelogenous Leukemia: Importance of Initial Cell Dose.
36. p53 over‐expression identifies a subset of nodal peripheral T‐cell lymphomas with a distinctive biological profile and poor clinical outcome
37. Expression of Myeloid Markers Lacks Prognostic Impact in Children Treated for Acute Lymphoblastic Leukemia: Italian Experience in AIEOP-ALL 88-91 Studies
38. p53 Expression in B-Cell Chronic Lymphocytic Leukemia: A Marker of Disease Progression and Poor Prognosis
39. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas
40. Acute Myeloid Leukemias M2, Potentially Misdiagnosed as M3 Variant French-American-Britain (FAB) Subtype: A Transitional Form?
41. Surgical approach to isolated mediastinal lymphoma.
42. Acute lymphocytic leukemia and complement receptors.
43. Heterogeneity of TdT +, HLA-DR + acute leukaemia: Immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin.
44. Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis
45. Peripheral T Cell Lymphoma in Adults: Morphological and Phenotypical Study of Four Cases
46. Secondary Acute non Lymphoid Leukemia in Patients Treated for non Hodgkin's Lymphoma: No Risk of Therapy-Related Anll after Provecip Schedule
47. Sequential Combination Chemotherapy of High-Grade Non-Hodgkin's Lymphoma with 5-Fluorouracil, Methotrexate, Cytosine-Arabinoside, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (F-MACHOP)
48. Impact of Relapse after Allogeneic Hematopoietic Stem Cell Transplant on Subsequent Outcome in Patients with Chronic Myeloid Leukemia: A Better Understanding through Multi-State Modeling.
49. Clinical relevance of immunological markers in acute lymphoblastic leukemia
50. Impiego sequenziale di ARA-C ad alte dosi ed asparaginasi (HIDAC+ASP) nel trattamento di leucemie acute e linfomi maligni in fase avanzata
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.